By design, the drug development process may seem overly complex, involving many teams that bring varied experience and expertise as they all drive research forward toward the goal of bringing an innovative new therapy to market and to the patients who stand to benefit from it. This approach – seen more as a qualitative process – typically includes a combination of clinical and non-clinical development teams, as well as medical affairs teams and epidemiologists who bring in real-world evidence and the patient experience. In the above video, Mat Davis, PhD, Vice President, Head of Data Science, Evidence and Value Generation defines quantitative drug development and discusses how Jazz takes a different approach to the more traditional, and often more siloed, qualitative process, one that harnesses quantitative processes and centers on real-world data to bring forward the maximum benefit for patients.
Simplifying the drug development process by leveraging focused and integrated quantitative methods is just one of the ways Jazz is innovating to transform the lives of patients. What makes us unique in the pharmaceutical industry is how we have centralized many of the data science functions into one department, breaking down the silos to fully embrace the value of data science and removing the barriers to drug development.
To learn more, click here to watch Mat Davis share insights on Jazz’s perspective on quantitative drug development at the 2023 STAT Eureka Conference. Mat also shared additional insights on the unique processes at Jazz on The Effective Statistician podcast. Listen here.
الإبلاغ عن أثر جانبي
إذا كنت ترغب في الإبلاغ عن أثر جانبي مرتبط بالمنتجات الدوائية لشركة Jazz Pharmaceuticals، يُرجى إرسال بريد إلكتروني إلينا عبر الرابط التالي:
يُرجى تقديم أكبر قدر ممكن من المعلومات المتاحة.
تشمل المعلومات ذات الصلة ما يلي:
بتقديمك لتقريرك وتزويدنا ببيانات الاتصال الخاصة بك، فإنك تُقرّ وتوافق صراحةً على أنه يجوز لقسم السلامة الدوائية المحلي التواصل معك بغرض طلب معلومات إضافية أو توضيحات، إذا اعتُبر ذلك ضروريًا لتقييم التقرير ومتابعته.
يوضح إشعار الخصوصية الخاص بنا المتعلق باليقظة الدوائية والمعلومات الطبية وشكاوى المنتجات كيفية تعامل شركة Jazz Pharmaceuticals مع معالجة المعلومات الشخصية عند التعامل مع تقريرالأثر الجانبي الخاص بك، وهو متاح في مركز الخصوصية لدينا.
Report an Adverse Event
If you want to report a Adverse Event related to Jazz Pharmaceuticals medicinal products, then please send us an e-mail via this link:
Please provide as much available information as possible.
Relevant information includes:
By submitting your report and providing your contact details, you expressly acknowledge and agree that the local drug safety department may contact you for the purpose of requesting additional information or clarifications, should this be deemed necessary for the assessment and follow‑up of the report.
Our Privacy Notice for Pharmacovigilance, Medical Information and Product Complaints outlines how Jazz Pharmaceuticals handles the processing of personal information when dealing with your adverse event report and is available in our Privacy Center.
